CTM Boost
Phase 3Biologic
CTM Boost is one of 8 biologic programs targeting Tendinopathy. It is currently in Phase 3.
1
Indications
1
Total Trials
1
Active Trials
7
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
10 competitors in Tendinopathy
#DrugCompanyPhaseTrials
1Voltaren
NovartisApproved
Aspercreme Warming
AAveritas Pharma, Inc.
Approved
Platelet Rich Plasma
ZZagazig University
Phase 3
Doryx
PPfizer's Upjohn has merged with Mylan to form Viatris Inc.
Phase 1
CTM Boost
AAllegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Phase 3
Aleve
Jazz PharmaceuticalsPreclinical
Naproxen Sodium
BayerPreclinical
Glyceryl - Trinitrate
PProcris Pharmaceuticals
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Tendinopathy1 trial
Connective Tissue Matrix for Rotator Cuff Tendinopathy
Active, not recruiting·—·Phase 4·NCT06160427·92 enrolled
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for CTM Boost. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details